chr10-69572485-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020999.4(NEUROG3):​c.559T>A​(p.Ser187Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000181 in 1,436,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

NEUROG3
NM_020999.4 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.77

Publications

0 publications found
Variant links:
Genes affected
NEUROG3 (HGNC:13806): (neurogenin 3) The protein encoded by this gene is a basic helix-loop-helix (bHLH) transcription factor involved in neurogenesis. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of congenital malabsorptive diarrhea 4 (DIAR4).[provided by RefSeq, May 2010]
NEUROG3 Gene-Disease associations (from GenCC):
  • congenital malabsorptive diarrhea 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • permanent neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26212823).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEUROG3NM_020999.4 linkc.559T>A p.Ser187Thr missense_variant Exon 2 of 2 ENST00000242462.5 NP_066279.2 Q9Y4Z2
NEUROG3XM_017016280.2 linkc.559T>A p.Ser187Thr missense_variant Exon 2 of 2 XP_016871769.1 Q9Y4Z2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEUROG3ENST00000242462.5 linkc.559T>A p.Ser187Thr missense_variant Exon 2 of 2 1 NM_020999.4 ENSP00000242462.4 Q9Y4Z2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000507
AC:
1
AN:
197354
AF XY:
0.00000921
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000120
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000181
AC:
26
AN:
1436524
Hom.:
0
Cov.:
37
AF XY:
0.0000210
AC XY:
15
AN XY:
712944
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32724
American (AMR)
AF:
0.00
AC:
0
AN:
40854
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25718
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38006
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83842
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50264
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5548
European-Non Finnish (NFE)
AF:
0.0000218
AC:
24
AN:
1100256
Other (OTH)
AF:
0.0000337
AC:
2
AN:
59312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 23, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.559T>A (p.S187T) alteration is located in exon 2 (coding exon 1) of the NEUROG3 gene. This alteration results from a T to A substitution at nucleotide position 559, causing the serine (S) at amino acid position 187 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
0.0044
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T
Eigen
Benign
0.011
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.081
D
MetaRNN
Benign
0.26
T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Benign
1.1
L
PhyloP100
3.8
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.26
Sift
Benign
0.075
T
Sift4G
Uncertain
0.039
D
Polyphen
0.47
P
Vest4
0.29
MutPred
0.25
Gain of glycosylation at S187 (P = 0.0477);
MVP
0.98
MPC
1.2
ClinPred
0.77
D
GERP RS
4.7
Varity_R
0.18
gMVP
0.74
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1224222918; hg19: chr10-71332241; API